Answers are grounded in this paper and cite their sources.
New research on pharmaceutical-industry sponsorship of clinical research in breast cancer shows that treatment trials funded by the industry are more likely to show positive results than studies sponsored by other sources. There are also major differences in trial design when drug companies are the funders.
No takes yet. Share an insight, caveat, or question.
Gardner et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: